NBFC firm IIFL Finance shares gained nearly 3% as the board of directors approved a ₹2,000 crore fundraise via NCDs in one or ...

IIFL Finance's board has decided that the NCD issue will also include a green shoe option, which is a provision that allows ...

In a stock exchange filing, the company said its board has approved a public issue of secured, rated, listed, redeemable ...

This also includes green shoe option, if any, in one or more tranches, IIFL Finance said in an exchange filing on Wednesday.

Analysts anticipate a Nifty range of 23,200-29,000 for next year, depending on the outcome of the India-US trade negotiations ...

IIFL Finance added 2.11% to Rs 568.80 after the company's board approved raising up to Rs 2,000 crore through debt instruments in multiple tranches.

Sudeep Pharma IPO GMP has fallen by 7.2% to Rs 90 (or nearly 15% premium over the issue price) on Thursday, compared with Rs ...

The board of IIFL Finance at its meeting held on 26 November 2025 has approved the public issue of secured, rated, listed, redeemable non-convertible debentures, with the shelf limit of up to Rs.

Sudeep Pharma sold its shares in the price band of Rs 563-593 apiece, applied for a minimum of 25 shares and its multiples to ...

Nifty closes above 26200 mark. Nifty snaps three-day losing streak. Nifty record biggest intraday gain since 26 June 2025.

Ravishanker Kovi, the founder and executive chairman of RK Pharma, commented that Zydus Life has a powerful commercial ...